RBOT News and Press, Vicarious Surgical Inc Com Cl A From 11/13/23

Vicarious Surgical Inc. Class A (RBOT) is expected to report $-0.15 for Q3 2023

2023-09-22 17:12:42 ET More on Vicarious Surgical Seeking Alpha’s Quant Rating on Vicarious Surgical Historical earnings data for Vicarious Surgical Financial information for Vicarious Surgical Vicarious Surgical: Huge Potential But Low Margin Of Safet...

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that on September 20...

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to enhance patient outcomes and improve the cost and efficiency of surgical procedures, announced it has signed a strategic deve...

2023-08-24 17:42:23 ET Summary Vicarious Surgical is a surgical robotics company developing a next-generation surgical robot with human-like dexterity. The company has a large addressable market of over 45 million abdominal procedures worth $150 billion, but its survival is uncert...

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the Company will partici...

2023-08-03 13:02:58 ET Gainers: Bluejay Diagnostics ( BJDX ) +73% . T2 Biosystems ( TTOO ) +67% . Traeger ( COOK ) +41% . Upwork ( UPWK ) +41% . Adamis Pharmaceuticals Corporation ( ADMP ) +40% . Motorsport Games ( MSGM )...

2023-08-03 10:16:24 ET Gainers: Bluejay Diagnostics ( BJDX ) +74% . Adamis Pharmaceuticals ( ADMP ) +59% . T2 Biosystems ( TTOO ) +47% . Community Health Systems ( CYH ) +18% . Cyclo Therapeutics ( CYTH ) +17% . Losers:...

2023-08-03 09:05:43 ET Aravive ( ARAV ) -58% announces top-line results from phase 3 AXLerate-OC study of batiraxcept in patinum-resistant ovarian cancer. Vicarious Surgical ( RBOT ) -41% on pricing $45M offering . DXC Technology Company ( DXC ) -24% ...

2023-08-03 05:35:19 ET Vicarious Surgical ( NYSE: RBOT ) prices 45M shares at a price to the public of $1.00 per share. Underwriters have a 30-day option to purchase up to an additional 6,750,000 shares. Gross proceeds of ~$45M. The offering is expected to close on...